According to our (Global Info Research) latest study, the global Pulmonary Embolectomy System market size was valued at US$ 1142 million in 2025 and is forecast to a readjusted size of US$ 1895 million by 2032 with a CAGR of 7.5% during review period.
Pulmonary embolectomy systems are specialized medical devices designed for the minimally invasive removal of thromboemboli from the pulmonary arteries to restore hemodynamic stability in patients with acute pulmonary embolism. These systems typically comprise aspiration catheters, mechanical thrombectomy devices, guidewires, and negative pressure aspiration pumps. Unlike traditional surgical embolectomy, catheter-based techniques achieve thrombus removal through percutaneous access, offering reduced procedural trauma, shorter hospital stays, and improved clinical outcomes for intermediate- and high-risk patients. Key technologies include large-bore aspiration catheters, mechanical fragmentation devices, and rheolytic thrombectomy systems. From a value chain perspective, upstream includes catheter material suppliers (medical-grade polymers, braiding wires), guidewire component manufacturers, aspiration pump and console producers, and packaging/sterilization service providers; midstream involves device assembly, quality control, regulatory certification (FDA, CE, NMPA), and distribution; downstream demand spans interventional cardiology departments, vascular surgery departments, interventional radiology departments, and intensive care units in hospitals. In 2025, the average selling price is approximately US$9,800 per unit, global sales volume is about 113.3k units, and gross margins generally range from 50% to 70%, driven by catheter material costs, device design complexity, regulatory approval barriers, and physician training requirements.
The pulmonary embolectomy system market is experiencing robust growth driven by the increasing global incidence of pulmonary embolism and the paradigm shift toward minimally invasive catheter-based interventions over traditional surgical embolectomy. According to the CDC, approximately 900,000 people in the United States are affected by deep vein thrombosis and pulmonary embolism annually, with about 60,000-100,000 deaths. This high disease burden, coupled with the availability of effective mechanical thrombectomy devices, has created substantial demand for pulmonary embolectomy systems.
Another key trend is the expansion of treatment guidelines that now recommend catheter-directed therapies for intermediate-risk pulmonary embolism patients. Previously, systemic anticoagulation was the standard of care for non-massive PE, but growing evidence supports the use of mechanical thrombectomy to reduce right ventricular strain, improve long-term functional outcomes, and prevent chronic thromboembolic pulmonary hypertension. This guideline expansion has significantly broadened the addressable patient population for pulmonary embolectomy systems.
The market is also witnessing significant technological innovation in next-generation thrombectomy devices. Key trends include the development of dual-action devices combining aspiration and mechanical fragmentation, enhanced navigability through complex pulmonary arterial anatomy, and real-time pressure monitoring for safer aspiration. These innovations are improving procedural efficienc
This report is a detailed and comprehensive analysis for global Pulmonary Embolectomy System market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Pulmonary Embolectomy System market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Pulmonary Embolectomy System market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Pulmonary Embolectomy System market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Pulmonary Embolectomy System market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Pulmonary Embolectomy System
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Pulmonary Embolectomy System market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Inari Medical, Inc., Penumbra, Inc., Boston Scientific Corporation, Medtronic plc, Teleflex Incorporated, Johnson & Johnson (Ethicon), Terumo Corporation, Kaneka Corporation, MicroPort Scientific Corporation, Lepu Medical Technology Co., Ltd., etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Pulmonary Embolectomy System market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Large-Bore Aspiration Catheter (> 12F)
Medium-Bore Aspiration Catheter (8-12F)
Small-Bore Aspiration Catheter (< 8F)
Market segment by Price Tier
Standard (< US$7,000)
Premium (US$7,000-15,000)
Integrated System (> US$15,000)
Market segment by Patient Risk Stratification
High-Risk PE (Massive)
Intermediate-Risk PE (Submassive)
Low-Risk PE
Market segment by Application
Tertiary / Academic Medical Center
Regional / Community Hospital
Specialized Cardiovascular Center
Major players covered
Inari Medical, Inc.
Penumbra, Inc.
Boston Scientific Corporation
Medtronic plc
Teleflex Incorporated
Johnson & Johnson (Ethicon)
Terumo Corporation
Kaneka Corporation
MicroPort Scientific Corporation
Lepu Medical Technology Co., Ltd.
Avinger, Inc.
Argon Medical Devices
Control Medical Technology
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Pulmonary Embolectomy System product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Pulmonary Embolectomy System, with price, sales quantity, revenue, and global market share of Pulmonary Embolectomy System from 2021 to 2026.
Chapter 3, the Pulmonary Embolectomy System competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Pulmonary Embolectomy System breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Pulmonary Embolectomy System market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Pulmonary Embolectomy System.
Chapter 14 and 15, to describe Pulmonary Embolectomy System sales channel, distributors, customers, research findings and conclusion.
Summary:
Get latest Market Research Reports on Pulmonary Embolectomy System. Industry analysis & Market Report on Pulmonary Embolectomy System is a syndicated market report, published as Global Pulmonary Embolectomy System Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032. It is complete Research Study and Industry Analysis of Pulmonary Embolectomy System market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.